The market for treatments for transthyretin amyloidosis was valued at USD 4.822 billion in 2020 and is projected to grow to USD 7.11 billion by 2025. The size of the worldwide market for amyloidosis treatments was estimated at USD 3.7 billion in 2018 and is projected to grow at a CAGR of 6.9% during the forecast period. Some of the reasons that will jointly drive the market are the expanding elderly population, the increased acceptance of innovative targeted treatments and transplantation, the introduction of biologics, and these.
Related Conference:
Neurological Disorders Conferences | Stroke Conferences | Parkinson’s Disease Conferences | Alzheimer’s Disease Conferences | Epilepsy Conferences | Psychiatry Conferences | Neurology Conferences | Dementia Conferences | Guillain Barre Syndrome Conferences | Ischemic Stroke Conferences | Neuroscience Conferences | Neurological Disorders Conference | Stroke Conference
Related Associations:
American Stroke Association | Spinal Cord Injury Association | World Federation of Neurology | American Neurological Association (ANA) | World Stroke Organization (WSO) | Dementia Society of America | Alzheimer's Disease International (ADI) | National Association of Epilepsy Centers | American Psychiatry Association | International Spinal Cord Injury Organizations | American Association of Neurological Surgeons | European Association for Neurological Disorders
Related Societies:
European Society of Stroke | Functional Neurological Disorder Society (FNDS) | Society of Ischemic Stroke Incidence | The International Spinal Cord Society | European Association of Neurosurgical Societies | European Society of Epilepsy | Dementia Society of America | Society of Guillian-Barre Syndrome | American Society of Stroke | Alzheimer’s Society of Europe | Parkinson’s Society of America
Related Journals:
International Journal of Stroke | American Academy of Neurology Journals | European Journal of Neurology | Journal of Neurological Disorders | Journal of Guillian-Barre Syndrome | Journal of Alzheimer’s Disease | Journal of Parkinson’s Diseases | Therapeutic Advances in Neurological Disorders | International Journal of Acute Ischemic Stroke | Journal of Dementia | International Journal of Epilepsy | American Journal of Psychiatry | European Journal of Neuroscience
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
